Genís (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Genís

An innovative Icelandic biotechnology company

Founded 2005 Iceland

Iceland 28 employees Series Unknown Total: $100.05M Biotechnology, Health Care +1

Genís is an innovative Icelandic biotechnology company that was founded in 2005 and is headquartered in Siglufjörður, Iceland. The company's mission is to discover, develop, and commercialize novel and life-changing pharmaceutical products, supplements, and medical devices derived from crustacean exoskeletons. With a focus on the production of chitin, chitosan, and chitin-derived oligosaccharides, the Genis team has been engaged in cutting-edge research for over two decades. Their goal is to provide life-altering benefits for individuals suffering from a broad spectrum of inflammatory and degenerative conditions. The company operates in the biotechnology and health care industries, positioning themselves at the intersection of science and public health. Notably, Genis recently secured a significant $17.00M Venture Round investment on 18 December 2022, with support from investors such as Yanu Holdings, Sigurgeir Gudlaugsson, TM, Sigþór Sigmarsson, and Andri Sveinsson. This financial backing is poised to drive the company's research and development efforts, as well as propel their mission to bring innovative healthcare solutions to market.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	••••••	5	•••• ••••	18 Dec 2022
Grant	••••••	1	•••• ••••	01 Mar 2017
Grant	••••••	1		01 Mar 2009
Grant	••••••	1		01 Mar 2008
Grant	••••••	1		01 Mar 2005

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

••••••

•••• ••••

18 Dec 2022

Grant

••••••

•••• ••••

01 Mar 2017

Grant

••••••

01 Mar 2009

Grant

••••••

01 Mar 2008

Grant

••••••

01 Mar 2005

FAQ About Genís

An innovative Icelandic biotechnology company

Genís was founded in 2005.

Genís is headquartered in Iceland.

Genís operates in the following industries: Biotechnology, Health Care, Medical Devices.

Genís has approximately 28 employees.

Genís has completed 6 funding rounds, raising a total of $100.05M. The latest funding stage is Series Unknown.

Top alternatives and competitors to Genís include Talecris Biotherapeutics, Inc., CuanTec, Celogics, uMed, Faesol Pte Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Genís and Talecris Biotherapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Genís

General Information

Track Genís

Discover More

About Genís

Funding Rounds & Investors (6)

Genís Alternatives & Competitors

FAQ About Genís

Don't just browse. Track.